Analysis of economic affordability of the antihypertensive therapy for the treatment of hypertension
DOI:
https://doi.org/10.24959/cphj.16.1392Keywords:
hypertension, affordability ratio, coefficient of the solvency adequacy, first line antihypertensive drugsAbstract
Hypertension (HTN) is a common disease, which main manifestation is high blood pressure (BP). Nowadays, HTN is found in 30-40% of the adult population of the world. The prevalence of HTN in the population increases with age. Among people aged 18-29 years old the prevalence of HTN is 4%; aged 50-59 years old – 44%; among people aged 60-69 years old – 54%, and aged 70 and older – 65%. The aim of this study was to evaluate the range and economic affordability of antihypertensive drugs. The analysis has shown that the range of the first line antihypertensive drugs includes 35 INNs of drugs represented by 570 TNs. Most part of the market – 68.5% is taken by foreign drugs and only 31.1% – by domestic drugs. The range of antihypertensive drugs includes drugs of different generations: in addition to well-known drugs there are also new ones that have significant advantages both in terms of clinical efficiency and safety. The analysis of economic affordability has shown that the vast majority of drugs are highly affordable for the Ukrainian consumers, and their total number when calculated at the maximum price is 54.3% (19 INNs) of all drugs presented at the Ukrainian pharmaceutical market. The share of drugs with average affordability is 37.1% (13 INNs); it allows the average citizen of Ukraine taking drugs during the entire treatment of HTN without experiencing a significant impact on his/her own budget, and only 8.6% (3 INNs) are drugs with low affordability. But drugs with low affordability are modern and have significant advantages when used in clinical practice compared to available analogs.
References
Голяченко О.М., Голяченко А.О. // Вісник наукових досліджень (Тернопільська державна медична академія ім. І.Я.Горбачевського). – 2011. – №4. – С. 38-41.
Горбась І.М., Смирнова І.П., Кваша О.О., Дорогой А.П. // Артериальная гипертензия. – 2010. – №6 (14). – С. 51-82.
Коваленко В.М., Корнацький В.М. Медико-соціальні аспекти хвороб системи кровообігу: Аналітично-статистичний посібник. – К., 2010. – 144 с.
Коваленко В.М., Корнацький В.М. Динаміка стану здоров’я народу України та регіональні особливості: Аналітично-статистичний посібник. – К., 2012. – 211 с.
Коваленко В.М., Корнацький В.М. Регіональні медико-соціальні проблеми хвороб системи кровообігу: Аналітично-статистичний посібник. – К., 2013. – 239 с.
Коваленко Н.В. Керівництво по кардіології. – К.: Морион, 2008. – 460 с.
Наказ МОЗ України від 24.05.2012 р. №384 «Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при артеріальній гіпертензії».
Програмний комплекс «Аптека» компанії «Моріон» [Електронний ресурс] – Режим доступу до сайту: http: //pharmbase.com.ua/poisk/.
Тиск у нормі – запорука здоров’я // Медичний світ. – 2014. – Електронний ресурс. – Доступ до статті: http://medsvit.org/articles/1/396/tisk-u-norm-zaporuka-zdorov-ya/&print=1
Яковлєва Л.В., Бондаренко Д.В. // Укр. біофармац. журн. – 2015. – №2 (37). – С. 4-10.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
